A detailed history of Stonnington Group, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Stonnington Group, LLC holds 4,450 shares of TXG stock, worth $59,363. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,450
Holding current value
$59,363
% of portfolio
0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 14, 2023

BUY
$35.33 - $55.79 $157,218 - $248,265
4,450 New
4,450 $248,000
Q2 2022

Jul 08, 2022

SELL
$36.95 - $82.41 $369,500 - $824,100
-10,000 Closed
0 $0
Q1 2022

Apr 12, 2022

BUY
$55.7 - $145.79 $557,000 - $1.46 Million
10,000 New
10,000 $726,000
Q3 2021

Oct 12, 2021

SELL
$145.58 - $192.14 $528,455 - $697,468
-3,630 Closed
0 $0
Q2 2021

Jul 09, 2021

BUY
$134.22 - $202.37 $487,218 - $734,603
3,630 New
3,630 $683,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.27B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Stonnington Group, LLC Portfolio

Follow Stonnington Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonnington Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonnington Group, LLC with notifications on news.